Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study
Authors:
Open Access
- 10 June 2024
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 105, 105187
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tauAlzheimer's & Dementia, 2020
- Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid‐deficient miceJournal of Inherited Metabolic Disease, 2020
- Pleiotropy of cardiometabolic syndrome with obesity-related anthropometric traits determined using empirically derived kinships from the Busselton Health StudyHuman Genetics, 2017
- Structural and functional roles of ether lipidsProtein & Cell, 2017
- Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis in miceHepatology, 2017
- Analysis of Plasmalogen Species in FoodstuffsLipids, 2016
- A statistical selection strategy for normalization procedures in LC‐MS proteomics experiments through dataset‐dependent ranking of normalization scaling factorsProteomics, 2011
- Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause MortalityJAMA, 2011
- Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab)Diabetologia, 2010
- Evidence that Plasmalogen is Protective Against Oxidative Stress in the Rat BrainNeurochemical Research, 2006